← Leaderboards
Jeffrey B. Mason
University Of Pennsylvania
$597,939
Attributed
$597,939
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $435K · FY2010–19$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$597,939 · 2
By mechanism
R15$434,997 · 1
F32$162,942 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Maurizio Pacifici$19,366,698
- Matthew B Fisher$5,129,113
- Louis J. Soslowsky$25,716,013
- Nathaniel A. Dyment$6,885,178
- Eiki Koyama$6,416,048
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignIn VivoSignal TransductionChronicGene ExpressionCellsExostosesExcisionFemaleDisease ProgressionAffectAdeno-Associated Viral VectorAnterior Cruciate LigamentAntibodiesEffectivenessClinical TreatmentBone ResorptionDegenerative PolyarthritisArthritisBiologyCellular TransductionDigital ImagingBoneAdult
Grant awards (4)
Identification of the mechanisms responsible for the ovary-dependent extension of longevity and health span$434,997
R15 · FY2019 · AG · contact PI
In Vivo Gene Therapy for Treatment of Osteoarthritis$57,734
F32 · FY2012 · AR · contact PI
In Vivo Gene Therapy for Treatment of Osteoarthritis$54,734
F32 · FY2011 · AR · contact PI
In Vivo Gene Therapy for Treatment of Osteoarthritis$50,474
F32 · FY2010 · AR · contact PI